Skip to content

Non-invasive Ventilation and Physical Activity

Non-invasive Ventilation and Physical Activity in Patients With Neuromuscular Disorders and Thoracic Wall Disorders

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02951572
Enrollment
8
Registered
2016-11-01
Start date
2013-02-28
Completion date
2017-06-30
Last updated
2020-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases

Keywords

Noninvasive Ventilation, Physical activity

Brief summary

As fatigue and daytime sleepiness are typical symptoms of alveolar hypoventilation in patients with neuromuscular disorders and thoracic deformations, we hope, by starting non-invasive ventilation and improving these symptoms, to increase their physical activity.

Detailed description

Patients with neuromuscular disorders and thoracic deformations develop alveolar hypoventilation during their disease progression. At that time, non-invasive ventilation(NIV) can be started as treatment. Fatigue and daytime sleepiness are typical symptoms of alveolar hypoventilation. NIV has the intention to improve these symptoms but no research has been performed whether these improvements also objectively improve physical activity. Further on, no research has been performed on muscle strength and muscle fatigue. Patients' physical activity, physical capacity and sleep quality will be measured before NIV initiation, after 3 months and 1 year of NIV use. To start NIV, patients will be admitted to our sleep laboratory for 5 days/4 nights. Polysomnography will be used during NIV titration. Physical activity will each time be measured by 2 activity monitors during 5 days.

Interventions

DEVICENIV

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* restrictive pulmonary function test AND * symptoms of nocturnal alveolar hypoventilation or * increased daytime pressure of arterial CO2 (PaCO2) (\>45 mmHg) or * \>= 10 mmHg increase in PaCO2 during sleep in comparison to a normal awake supine value

Exclusion criteria

* patients \< 16 years * severe cardiac arrythmias or conduction disturbances * severe mental disturbances * amyotrophic lateral sclerosis * total wheelchair-dependent patients

Design outcomes

Primary

MeasureTime frameDescription
Average daily walking timeMeasured before initiation of NIVAverage daily walking time will be measured by the McRoberts physical activity monitor

Secondary

MeasureTime frameDescription
Change in functional exercise capacityBefore NIV initiationSix minute walking test
Change in muscle strengthBefore NIV initiationQuadriceps muscle strength will be measured by magnetic stimulation. MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
Change in quadriceps fatiguabilityBefore NIV intiationUse of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
Change in sleep structure and quality of sleepBefore NIV intiationFull polysomnography will be used to get insight in sleep improvement

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026